Assessment of safety and effectiveness of oral multiple sclerosis medication

Abdulrahman M. Al Turaiki; Maha A. Al Ammari; Dalal A. Alabdulkarim; Abdullah U. Althemery

doi:10.15537/smj.2019.11.24630

Article Information

vol. 40 no. 11 1116-1122

DOI

https://doi.org/10.15537/smj.2019.11.24630

PubMed

31707408

Published By

Saudi Medical Journal

Online ISSN

1658-3175

History

Received July 29, 2019
Accepted October 9, 2019
Published online November 1, 2019.

Copyright: © Saudi Medical Journal This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Author Information

Abdulrahman M. Al Turaiki, B. Pharm,
Maha A. Al Ammari, Msc MPH,
Dalal A. Alabdulkarim, Msc Pharm and
Abdullah U. Althemery, PhD ⇑

From the Pharmaceutical Care Services, Ministry of the National Guard- Health Affairs (Al Turaiki, Al Ammari, Alabdulkarim), King Abdullah International Medical Research Center, and King Saud bin Abdulaziz University for Health Sciences, Riyadh; and from the Clinical Pharmacy Department (Althemery), College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj, Kingdom of Saudi Arabia

Address correspondence and reprint request to: Dr. Abdullah Althemery, Assistant Professor, Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Kingdom of Saudi Arabia. E-mail: a.althemery{at}psau.edu.sa ORCID: https://orcid.org/0000-0002-3415-7685

View Full Text